BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37723974)

  • 21. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.
    Tada H; Shiffman D; Smith JG; Sjögren M; Lubitz SA; Ellinor PT; Louie JZ; Catanese JJ; Engström G; Devlin JJ; Kathiresan S; Melander O
    Stroke; 2014 Oct; 45(10):2856-2862. PubMed ID: 25123217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study.
    Perez MV; Wang PJ; Larson JC; Soliman EZ; Limacher M; Rodriguez B; Klein L; Manson JE; Martin LW; Prineas R; Connelly S; Hlatky M; Wassertheil-Smoller S; Stefanick ML
    Heart; 2013 Aug; 99(16):1173-8. PubMed ID: 23756655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Atrial Fibrillation and Dementia in the General Population.
    de Bruijn RF; Heeringa J; Wolters FJ; Franco OH; Stricker BH; Hofman A; Koudstaal PJ; Ikram MA
    JAMA Neurol; 2015 Nov; 72(11):1288-94. PubMed ID: 26389654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    Eur Heart J; 2019 May; 40(19):1504-1514. PubMed ID: 30605505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.
    Chang SH; Kuo CF; Chou IJ; See LC; Yu KH; Luo SF; Huang LH; Zhang W; Doherty M; Wen MS; Kuo CT; Yeh YH
    JAMA Cardiol; 2017 Aug; 2(8):863-870. PubMed ID: 28678986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Risk Score for the Prediction of Incident Atrial Fibrillation: Derivation in 7 220 654 Taiwan Patients With 438 930 Incident Atrial Fibrillations During a 16-Year Follow-Up.
    Chao TF; Chiang CE; Chen TJ; Liao JN; Tuan TC; Chen SA
    J Am Heart Assoc; 2021 Sep; 10(17):e020194. PubMed ID: 34459227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.
    Hobbelt AH; Siland JE; Geelhoed B; Van Der Harst P; Hillege HL; Van Gelder IC; Rienstra M
    Europace; 2017 Feb; 19(2):226-232. PubMed ID: 28175276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium.
    Morseth B; Geelhoed B; Linneberg A; Johansson L; Kuulasmaa K; Salomaa V; Iacoviello L; Costanzo S; Söderberg S; Niiranen TJ; Vishram-Nielsen JKK; Njølstad I; Wilsgaard T; Mathiesen EB; Løchen ML; Zeller T; Blankenberg S; Ojeda FM; Schnabel RB;
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34341095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use and incident atrial fibrillation in a longitudinal cohort.
    Teraoka JT; Tang JJ; Delling FN; Vittinghoff E; Marcus GM
    Heart Rhythm; 2024 Apr; 21(4):370-377. PubMed ID: 38142832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort.
    Van Deutekom C; Geelhoed B; Van Munster BC; Bakker SJL; Gansevoort RT; Van Gelder IC; Rienstra M
    Open Heart; 2023 Jul; 10(2):. PubMed ID: 37460268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of clinical atrial fibrillation and related complications using a screening algorithm at a nationwide level.
    Roger A; Cottin Y; Bentounes SA; Bisson A; Bodin A; Herbert J; Maille B; Zeller M; Deharo JC; Lip GYH; Fauchier L
    Europace; 2023 May; 25(5):. PubMed ID: 36938977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of Blood Pressure and Body Mass Index With Risk of Incident Atrial Fibrillation in a Japanese Urban Cohort: The Suita Study.
    Kokubo Y; Watanabe M; Higashiyama A; Nakao YM; Kobayashi T; Watanabe T; Okamura T; Okayama A; Miyamoto Y
    Am J Hypertens; 2015 Nov; 28(11):1355-61. PubMed ID: 25845964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population - The Suita Study.
    Kokubo Y; Watanabe M; Higashiyama A; Nakao YM; Kusano K; Miyamoto Y
    Circ J; 2017 Oct; 81(11):1580-1588. PubMed ID: 28539563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation.
    Shoemaker MB; Husser D; Roselli C; Al Jazairi M; Chrispin J; Kühne M; Neumann B; Knight S; Sun H; Mohanty S; Shaffer C; Thériault S; Rinke LL; Siland JE; Crawford DM; Ueberham L; Zardkoohi O; Büttner P; Geelhoed B; Blum S; Aeschbacher S; Smith JD; Van Wagoner DR; Freudling R; Müller-Nurasyid M; Montgomery J; Yoneda Z; Wells Q; Issa T; Weeke P; Jacobs V; Van Gelder IC; Hindricks G; Barnard J; Calkins H; Darbar D; Michaud G; Kääb S; Ellinor P; Natale A; Chung M; Nazarian S; Cutler MJ; Sinner MF; Conen D; Rienstra M; Bollmann A; Roden DM; Lubitz S
    Circ Arrhythm Electrophysiol; 2020 Mar; 13(3):e007676. PubMed ID: 32078373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
    Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
    Kannel WB; Wolf PA; Benjamin EJ; Levy D
    Am J Cardiol; 1998 Oct; 82(8A):2N-9N. PubMed ID: 9809895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.
    Guan B; Li X; Xue W; Tse G; Waleed KB; Liu Y; Zheng M; Wu S; Xia Y; Ding Y
    J Clin Lipidol; 2020; 14(1):133-142.e3. PubMed ID: 31926850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation.
    Deng X; Hou J; Deng Q; Zhong Z
    Lipids Health Dis; 2021 Sep; 20(1):123. PubMed ID: 34587962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.